Adam Korayem, MD, PhD Email Adam Korayem
- ASSISTANT PROFESSOR | Surgery, Vascular Surgery
- ASSISTANT PROFESSOR | Diagnostic, Molecular and Interventional Radiology
- Vascular Surgery
- Hospital Affiliations
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Brooklyn
- Mount Sinai Beth Israel
- New York Eye and Ear Infirmary of Mount Sinai
Adam Korayem, MD, PhD, is an Assistant Professor of Vascular Surgery at Mount Sinai West, Mount Sinai Morningside, and The Mount Sinai Hospital.
Dr. Korayem earned his MD and PhD degrees from Rutgers University, New Jersey Medical School in 2015 and completed his training in vascular surgery at The Mount Sinai Hospital in 2020.
His PhD in vascular physiology contributed to our understanding of how the microcirculation responds to ischemia/reperfusion injury. An extension of his graduate work and a current clinical focus is to find ways to mitigate the often-deleterious effects of ischemia/reperfusion on the vascular system. Dr. Korayem is a collaborator with the laboratory of Dr. Jason Kovacic at the Icahn School of Medicine and is working to understand how specific cells within the microcirculation contribute to cardiovascular disease and vein graft failure. Dr. Korayem has won numerous awards throughout his training including the Vascular Techniques and Tech Think Tank (VAST3) 2019 Fellows competition. He has co-authored multiple peer-reviewed manuscripts and has traveled extensively to present his research at many national and regional meetings.
In addition to being passionate about research, Dr. Korayem has taught numerous undergraduate and graduate courses in basic science and vascular surgery at Hunter College, Sophie Davis School of Biomedical Education and the Icahn School of Medicine at Mount Sinai (ISMMS). He currently serves as a co-clerkship director for the surgery clerkship at ISMMS.
MD,PHD, Rutgers University New Jersey Medical School
Residency, Vascular Surgery
Icahn School of Medicine/Mount Sinai Hospital
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Korayem did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.